Development of a Pediatric Acute Asthma Prediction Rule for severity and outcome
Development of a Pediatric Acute Asthma Prediction Rule for severity and outcome
批准号:
8232029
负责人:
DONALD Hayes ARNOLD
金额:
$14.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-15 至 2013-02-28
关键词:
Accident and Emergency departmentAcuteAdmission activityAdolescentAgeAgonistAirway ResistanceAsthmaCaringChildChildhoodChronic DiseaseClinicalDataData ElementDevelopmentDisease ManagementEnrollmentFutureHome environmentHospitalsHourLength of StayMathematicsMeasuresMedicalModelingNatureNursesOutcomeParticipantPatient CarePersonsPhysical ExaminationPhysiciansPhysiologic pulsePhysiologicalProspective StudiesPulmonary function testsRelapseRisk FactorsSensitivity and SpecificitySeveritiesSeverity of illnessSpirometryStudy SubjectSystemTestingTherapeuticTimeValidity and Reliabilityabstractingairway obstructiondata integrationimprovedmembernovelrespiratoryresponsetrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose to develop a multivariable Asthma Prediction Rule (APR) conforming to clinical and biostatistical standards for clinical prediction rule development. The APR will include physical findings, vital signs, and objective physiologic variables obtained at presentation to an acute care facility, and trends of this data over the first 6 hours of care. This data is gathered by multiple members of a medical team, but is infrequently utilized in a coherent and systematic manner to optimally advance patient care. The APR will use those elements of data that are statistically demonstrated to predict the need for in-hospital care. In addition, we will further develop and validate a mathematic model using physiologic waveform data from the pulse oximeter as a candidate predictor variable for the APR. The novel integration of this data into the APR might enhance the predictive validity and reliability of the APR to be developed. Primary Aim: To determine independent risk factors in persons with asthma exacerbations that are associated with the need for in-hospital care. We hypothesize that select predictor variables can be utilized in an APR that will in turn predict need for in-hospital care with sufficient sensitivity and specificity to objectively inform clinical decisions. To test this hypothesis we will conduct a prospective study of children ages 7-17 years who present to a Pediatric Emergency Department with asthma exacerbations.Physical examination findings, vital signs, and objective physiologic variables obtained at presentation and during the first 6 hours of care will be used as candidate predictor variables to predict either hospital length of stay greater than 1 day if the participant is admitted to hospital, or relapse within 48 hours if discharged to home. This data will be utilized for the development of an APR in accordance with established clinical and biostatistical standards. Secondary Aim: To further develop and validate a real-time, continuous asthma severity measure using quantified oximeter plethysmograph waveform data that can be used and tested simultaneously as a candidate predictor variable for the APR. We hypothesize that an established mathematic model for oximeter Plethysmograph Estimated Pulsus paradoxus (PEP) will provide an effort-independent, real-time, continuous and valid estimate of the severity of airway obstruction for incorporation in the APR. To test this hypothesis, PEP will be statistically compared with the criterion standards of spirometry and specific airway resistance. (End of Abstract)
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Variability of the Acute Asthma Intensity Research Score in the pediatric emergency department.
儿科急诊科急性哮喘强度研究评分的变异性。
DOI:
10.1016/j.anai.2015.06.007
发表时间:
2015
期刊:
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
影响因子:
--
作者:
[O'Connor,MichaelGlenn, Berg,Kathleen, Stack,LawrenceB, Arnold,DonaldH]
通讯作者:
Arnold,DonaldH
DOI:
10.1136/emj.2010.110957
发表时间:
2012-06
期刊:
Emergency medicine journal : EMJ
影响因子:
--
作者:
[Arnold DH, Gebretsadik T, Abramo TJ, Sheller JR, Resha DJ, Hartert TV]
通讯作者:
Hartert TV
Exhaled nitric oxide is associated with severity of pediatric acute asthma exacerbations.
呼出的一氧化氮与小儿哮喘急性发作的严重程度有关。
DOI:
10.1016/j.jaip.2014.04.004
发表时间:
2014
期刊:
The journal of allergy and clinical immunology. In practice
影响因子:
--
作者:
[Langley,EmilyW, Gebretsadik,Tebeb, Hartert,TinaV, PeeblesJr,RStokes, Arnold,DonaldH]
通讯作者:
Arnold,DonaldH
DOI:
10.1097/aci.0000000000000259
发表时间:
2016-06
期刊:
Current opinion in allergy and clinical immunology
影响因子:
2.8
作者:
[Arnold DH, Sills MR, Walsh CG]
通讯作者:
Walsh CG
Pulse Oximeter Plethysmograph Estimate of Pulsus Paradoxus as a Measure of Acute Asthma Exacerbation Severity and Response to Treatment.
脉搏血氧计体积描记器估计奇异脉作为哮喘急性发作严重程度和治疗反应的衡量标准。
DOI:
10.1111/acem.12886
发表时间:
2016
期刊:
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
影响因子:
--
作者:
[Arnold,DonaldH, Wang,Li, Hartert,TinaV]
通讯作者:
Hartert,TinaV
共 12 条
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
-
批准号:10649012
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2023
-
负责人:DONALD Hayes ARNOLD
-
依托单位:
Pulse Oximeter Innovation to Measure Pulsus Paradoxus and Respiratory Disease Severity
-
批准号:9046119
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2016
-
负责人:DONALD Hayes ARNOLD
-
依托单位:
Development of a Pediatric Acute Asthma Prediction Rule for severity and outcome
-
批准号:8038324
-
项目类别:
-
资助金额:$14.77万
-
财政年份:2008
-
负责人:DONALD Hayes ARNOLD
-
依托单位:
Development of a Pediatric Acute Asthma Prediction Rule for severity and outcome
-
批准号:7385445
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2008
-
负责人:DONALD Hayes ARNOLD
-
依托单位:
Development of a Pediatric Acute Asthma Prediction Rule for severity and outcome
-
批准号:7777333
-
项目类别:
-
资助金额:$14.77万
-
财政年份:2008
-
负责人:DONALD Hayes ARNOLD
-
依托单位:
Development of a Pediatric Acute Asthma Prediction Rule for severity and outcome
-
批准号:7585292
-
项目类别:
-
资助金额:$14.77万
-
财政年份:2008
-
负责人:DONALD Hayes ARNOLD
-
依托单位:
海外基金